Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation

Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation

BackgroundSex‐specific effectiveness of rivaroxaban (RIVA), dabigatran (DABI), and warfarin in reducing myocardial infarction (MI), heart failure (HF), and all‐cause mortality among patients with atrial fibrillation are not known. We assessed sex‐specific associations of RIVA, DABI, or warfarin use...

Full description

Bibliographic Details
Main Authors: Ghanshyam Palamaner Subash Shantha, Amgad Mentias, Chakradhari Inampudi, Anita A. Kumar, Kongkiat Chaikriangkrai, Viraj Bhise, Abhishek Deshmukh, Nileshkumar Patel, Samir Pancholy, Phillip A. Horwitz, Steven Mickelsen, Prashant D. Bhave, Michael Giudici, Hakan Oral, Mary S. Vaughan Sarrazin
Format: Article
Language:English
Published: Wiley 2017-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
heart failure
mortality
myocardial infarction
sex
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006381

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.006381

Similar Items